Back to Results
First PageMeta Content
Biology / SLC5A2 / Diabetes mellitus / Insulin / Anti-diabetic medication / Metformin / Sodium-glucose transport proteins / Glycated hemoglobin / Diabetes management / Diabetes / Endocrine system / Medicine


For Immediate Release Astellas Announces Oral Presentation of SGLT2 Inhibitor Detailing Safety and Efficacy in Patients with Type 2 Diabetes at the European Association for the Study of Diabetes Meeting TOKYO, September
Add to Reading List

Document Date: 2011-09-15 04:30:05


Open Document

File Size: 29,88 KB

Share Result on Facebook
UPDATE